|
|
.
See Category: Diseases of the musculoskeletal system and connective tissue
ICD-10 (CM) Code and Descriptor
|
M45.9 |
Ankylosing spondylitis of unspecified sites in spine
|
M459 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 34.90%
|
16.60%
|
11.47%
|
8.69%
|
6.56%
|
5.59%
|
4.12%
|
2.92%
|
2.06%
|
1.90%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for M45.9*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
2,946
|
2,948
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
2,749
|
2,750
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
2,641
|
2,656
|
|
80053
|
COMPREHEN METABOLIC PANEL |
2,471
|
2,472
|
|
96413
|
CHEMO IV INFUSION 1 HR |
2,374
|
2,374
|
|
86140
|
C-REACTIVE PROTEIN |
2,346
|
2,346
|
|
85652
|
RBC SED RATE AUTOMATED |
1,890
|
1,890
|
|
96415
|
CHEMO IV INFUSION ADDL HR |
1,810
|
1,975
|
|
J1745
|
INFLIXIMAB NOT BIOSIMIL 10MG |
1,697
|
91,208
|
|
97110
|
THERAPEUTIC EXERCISES |
1,428
|
2,620
|
|
J7050
|
NORMAL SALINE SOLUTION INFUS |
1,135
|
1,182
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
948
|
951
|
|
J1602
|
GOLIMUMAB FOR IV USE 1MG |
916
|
126,363
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
820
|
1,141
|
|
97530
|
THERAPEUTIC ACTIVITIES |
797
|
1,314
|
|
82565
|
ASSAY OF CREATININE |
729
|
729
|
|
J0717
|
CERTOLIZUMAB PEGOL INJ 1MG |
693
|
261,126
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
692
|
852
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
682
|
1,524
|
|
Q5103
|
INJECTION, INFLECTRA |
567
|
27,252
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
M45.9 related to the following DRG Codes:
545-547
|
